Clinical significance of CD166 and HER-2 in different types of gastric cancer
Article in Clinical and Translational Oncology (August 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Trastuzumab Deruxtecan Dosing in Human Epidermal Growth Factor Receptor 2‐Positive Gastric Cancer: Population Pharmacokinetic Modeling and Exposure–Response Analysis
Article in The Journal of Clinical Pharmacology (July 2023)
Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
Article in World Journal of Gastroenterology (March 2017)